ICU Medical ($ICUI) Chief Operating Officer Christian B. Voigtlander sold 8,929 shares of company stock on August 11, 2026, in an open-market transaction valued at approximately $1.63 million. The shares were sold at an average price of $182.93 each, and Voigtlander filed the required Form 4 with the Securities and Exchange Commission the same day.
Following the transaction, Voigtlander held 37,377 shares of ICU Medical.
The sale occurred during a period of increased trading activity in $ICUI shares. During the first full trading week of August 2026, the stock traded between an intraday low of $164.09 on August 6 and an intraday high of $192.85 on August 7. The August 7 session saw the stock rise roughly 11% from the prior day's close of $166.37 to finish at $184.56, a move that followed the company's second-quarter earnings report, which was released after the market closed on August 6. Volume on August 7 reached 931,261 shares, compared with daily volumes of roughly 320,000 to 579,000 shares earlier in the week. On August 10, $ICUI closed at $182.42, and Voigtlander executed his sale the following day at $182.93 per share.
Voigtlander's disposition at $182.93 was executed at a price well above his prior open-market sales. In late May 2025, he sold 4,945 shares at $131.00 on May 27 and another 4,985 shares at $128.50 on May 28, for combined proceeds of approximately $1.29 million. Between those transactions and the August 2026 sale, his reported share ownership increased from 6,088 shares to 46,306 shares prior to the sale, reflecting equity grants received during the intervening fourteen months.
The COO's sale followed several other insider dispositions at ICU Medical earlier in 2026. President Daniel Woolson sold 2,123 shares at $132.21 on May 22, Vice President Virginia Ruth Sanzone sold 2,447 shares at $124.08 on May 14, and Director David C. Greenberg sold 2,424 shares at $122.91 on May 12. Collectively, these three open-market sales represented approximately $882,000 in proceeds.
ICU Medical insiders have also purchased shares on the open market at lower price levels. In August 2025, Chief Executive Officer Vivek Jain executed two separate open-market purchases totaling approximately $2.47 million: 2,378 shares at $112.12 and 19,551 shares at $112.92, both on August 14. Later that month, Director David C. Greenberg made two purchases on August 27, acquiring 602 shares at $126.14 and 598 shares at $126.69, for a combined outlay of roughly $152,000.
ICU Medical, headquartered in San Clemente, California, develops and manufactures intravenous therapy products, infusion pumps, and vascular access devices. The company trades on the Nasdaq under the ticker $ICUI and is classified in the health care sector.